ANOCCA (IEU TI)
Signed · Sweden
Source: European Investment Bank (EIB)
The promoter's technologies enable highly precise and efficient analysis of T-cell immunity required to deliver a range of therapeutics and vaccines that specifically harness or manipulate T-cell immunity. With a focus on delivering T-cell receptor modified T-cell therapies (TCR-T) in oncology, the promoter is rapidly progressing a pipeline of novel therapies towards clinical trials utilising its
- Status
- Under Construction
- Sector
- Hospital, Manufacturing (Industrial), Government
- Location
- Sweden
- Updated
- 22 Jul 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about ANOCCA (IEU TI)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | signed |
Taiyo status | Under Construction |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The promoter's technologies enable highly precise and efficient analysis of T-cell immunity required to deliver a range of therapeutics and vaccines that specifically harness or manipulate T-cell immunity. With a focus on delivering T-cell receptor modified T-cell therapies (TCR-T) in oncology, the promoter is rapidly progressing a pipeline of novel therapies towards clinical trials utilising its own manufacturing capabilities. The promoter's breakthrough technology has high market potential to address multiple indications and unmet medical needs, well aligned with EU policy priorities. The EIB project will support development of pre-clinical and clinical pipeline of therapeutics, as well as upgrading to Good Manufacturing Practices (GMP) certification the company's own manufacturing unit. |
Original sector | Services |
Location
Country | Sweden |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Hospital, Manufacturing (Industrial), Government |
Article published date | 2025-07-28 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Sweden
- Pfizer Genotropin Manufacturing, Strangnas
- Pronova Biopharma Pharmaceutical Production Facility
- GEA Niro Pharmaceutical Spray Drying Facility, Copenhagen
- Kemwell Pharmaceutical Manufacturing Facility
- Pre-A market expansion to SaaS and Clinical Seq
- Active moisture control for active people
- Cobra Biologics Manufacturing Facility Expansion, Matfors
- HELSINGBORG HOSPITAL
